Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PLC expects US de-listing after standards failings

This article was originally published in Clinica

Executive Summary

Cardiac and vascular product developer PLC Systems has said it expects to be de-listed from the American Stock Exchange (AMEX) sometime in the coming weeks as it has failed to prove its ability to regain compliance with listing standards. Franklin, Massachusetts-based PLC said its shareholder equity was less than $4m as of June 30 2008, and it incurred losses from continuing operations and net losses in three out of the four most recent fiscal years. The firm, which has been trading at less than $1 per share since September 2006, now expects to begin trading on the over-the-counter bulletin board.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042513

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel